These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies. Zane LT; Chanda S; Jarnagin K; Nelson DB; Spelman L; Gold LS Immunotherapy; 2016 Jul; 8(8):853-66. PubMed ID: 27283509 [TBL] [Abstract][Full Text] [Related]
12. Crisaborole (Eucrisa) for Mild to Moderate Atopic Dermatitis. Castelli G; Schaffer M Am Fam Physician; 2018 Sep; 98(6):379-380. PubMed ID: 30215912 [No Abstract] [Full Text] [Related]
13. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. Paller AS; Tom WL; Lebwohl MG; Blumenthal RL; Boguniewicz M; Call RS; Eichenfield LF; Forsha DW; Rees WC; Simpson EL; Spellman MC; Stein Gold LF; Zaenglein AL; Hughes MH; Zane LT; Hebert AA J Am Acad Dermatol; 2016 Sep; 75(3):494-503.e6. PubMed ID: 27417017 [TBL] [Abstract][Full Text] [Related]
14. Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression Analysis. Purohit V; Riley S; Tan H; Ports WC J Clin Pharmacol; 2020 Oct; 60(10):1344-1354. PubMed ID: 32433779 [TBL] [Abstract][Full Text] [Related]
15. Topical treatment utilization for patients with atopic dermatitis in the United States, and budget impact analysis of crisaborole ointment, 2. Clark R; Bozkaya D; Levenberg M; Faulkner S; Smith TW; Gerber RA J Med Econ; 2018 Aug; 21(8):770-777. PubMed ID: 29706103 [TBL] [Abstract][Full Text] [Related]
16. 2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis. Cheape AC; Murrell DF Expert Rev Clin Immunol; 2017 May; 13(5):415-423. PubMed ID: 28290219 [TBL] [Abstract][Full Text] [Related]
18. Crisaborole reverses dysregulation of the mild to moderate atopic dermatitis proteome toward nonlesional and normal skin. Kim M; Del Duca E; Cheng J; Carroll B; Facheris P; Estrada Y; Cha A; Werth J; Bissonnette R; Nocka K; Zang C; Pavel AB; Guttman-Yassky E J Am Acad Dermatol; 2023 Aug; 89(2):283-292. PubMed ID: 37054814 [TBL] [Abstract][Full Text] [Related]
19. Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis. Jarnagin K; Chanda S; Coronado D; Ciaravino V; Zane LT; Guttman-Yassky E; Lebwohl MG J Drugs Dermatol; 2016 Apr; 15(4):390-6. PubMed ID: 27050693 [TBL] [Abstract][Full Text] [Related]
20. Topical Crisaborole in the Treatment of Atopic Hand Dermatitis: A Retrospective Chart Review. Kahn JS; Grossman-Kranseler JS; Zancanaro P; Griffiths D; Dumont N; Rosmarin D Dermatitis; 2021 Nov-Dec 01; 32(6):e141-e143. PubMed ID: 34570730 [No Abstract] [Full Text] [Related] [Next] [New Search]